These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12584874)

  • 21. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group.
    Daughton D; Susman J; Sitorius M; Belenky S; Millatmal T; Nowak R; Patil K; Rennard SI
    Arch Fam Med; 1998; 7(5):425-30. PubMed ID: 9755734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New medications for nicotine dependence treatment.
    Hurt RD
    Nicotine Tob Res; 1999; 1 Suppl 2():S175-9; discussion S207-10. PubMed ID: 11768177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking cessation patterns in methadone-maintained smokers.
    Stein MD; Anderson BJ; Niaura R
    Nicotine Tob Res; 2007 Mar; 9(3):421-8. PubMed ID: 17365774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of two levels of adjunctive treatment used with the nicotine patch.
    Lifrak P; Gariti P; Alterman AI; McKay J; Volpicelli J; Sparkman T; O'Brien C
    Am J Addict; 1997; 6(2):93-8. PubMed ID: 9134070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Lancaster T
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000146. PubMed ID: 18253970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of varying levels of disease management on smoking cessation: a randomized trial.
    Ellerbeck EF; Mahnken JD; Cupertino AP; Cox LS; Greiner KA; Mussulman LM; Nazir N; Shireman TI; Resnicow K; Ahluwalia JS
    Ann Intern Med; 2009 Apr; 150(7):437-46. PubMed ID: 19349629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of bupropion in the management of smoking cessation.
    Jorenby D
    Drugs; 2002; 62 Suppl 2():25-35. PubMed ID: 12109933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
    Crane R
    Prim Care; 2007 Mar; 34(1):117-35. PubMed ID: 17481990
    [No Abstract]   [Full Text] [Related]  

  • 34. [Randomized clinical trial: effectiveness of the cognitive-behavioral approach and the use of nicotine replacement transdermal patches for smoking cessation among adults in Rio de Janeiro, Brazil].
    Otero UB; Perez Cde A; Szklo M; Esteves GA; dePinho MM; Szklo AS; Turci SR
    Cad Saude Publica; 2006 Feb; 22(2):439-49. PubMed ID: 16501756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
    Saxon AJ; Baer JS; Davis TM; Sloan KL; Malte CA; Fitzgibbons K; Kivlahan DR
    Nicotine Tob Res; 2003 Aug; 5(4):589-96. PubMed ID: 12959797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2001; (3):CD000146. PubMed ID: 11686953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bupropion: a review of its use in the management of smoking cessation.
    Holm KJ; Spencer CM
    Drugs; 2000 Apr; 59(4):1007-24. PubMed ID: 10804045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended cognitive behavior therapy for cigarette smoking cessation.
    Killen JD; Fortmann SP; Schatzberg AF; Arredondo C; Murphy G; Hayward C; Celio M; Cromp D; Fong D; Pandurangi M
    Addiction; 2008 Aug; 103(8):1381-90. PubMed ID: 18855829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing the tolerability and effectiveness of two treatment regimens in a smoking clinic.
    Sherman SE; Aldana I; Estrada M; York L
    Mil Med; 2008 Jun; 173(6):550-4. PubMed ID: 18595418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.